Post-Operative Morbidity and Mortality Following Total Neoadjuvant Therapy Versus Conventional Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer

ConclusionThis large-scale analysis of patients with LARC demonstrates increased utilization of TNT in patients harboring node-positive disease. Further, TNT does not appear to increase 30-day post-operative mortality, readmissions, or hospital LOS.

http://link.springer.com/10.1007/s12029-020-00401-3

Source: Journal of Gastrointestinal Cancer - September 15, 2020 Category: Cancer & Oncology Source Type: research